CompletedPhase 2NCT00991068

Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome

Studying NON RARE IN EUROPE: Carpal tunnel syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
ZARS Pharma Inc.
Principal Investigator
Srinivas Nalamachu, MD
International Clinical Research Institute
Intervention
Synera (lidocaine 70 mg and tetracaine 70 mg) topical patch(drug)
Enrollment
24 enrolled
Eligibility
18 years · All sexes
Timeline
20092010

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00991068 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Carpal tunnel syndrome

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Carpal tunnel syndrome

← Back to all trials